These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37860577)

  • 1. The COVID-19 shock and the ownership of store Chain：Evidence from China's express delivery industry.
    Shang L; Liu Y; Xu P
    Heliyon; 2023 Oct; 9(10):e20799. PubMed ID: 37860577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of the COVID-19 Pandemic on Consumer Behavior-Evidence From China's Stock Market.
    Lu Z; Zhu L; Li X; Li Z
    Front Public Health; 2022; 10():865470. PubMed ID: 36148367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?-Empirical Evidence From COVID-19.
    Li J; Ma Y; Shi B; Yang Y
    Front Public Health; 2021; 9():812253. PubMed ID: 35155358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the COVID-19 Pandemic on China's Airline Industry.
    Zhang Y; Zhu L; Hao F
    Front Public Health; 2022; 10():865463. PubMed ID: 35692311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Passenger Risk Perception During the COVID-19 Pandemic on Airline Industry: Evidence From the United States Stock Market.
    Lu Z; Zhu L; Li Z; Liang X; Zhang Y
    Front Psychol; 2021; 12():795940. PubMed ID: 35058854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the internationalization of China's new retail industry on corporate performance-A moderating effect based on proprietary assets.
    Lin LW; Wei SY
    PLoS One; 2022; 17(5):e0267825. PubMed ID: 35622859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional investors and cost of capital: The moderating effect of ownership structure.
    Huo X; Lin H; Meng Y; Woods P
    PLoS One; 2021; 16(4):e0249963. PubMed ID: 33831116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indifferent to CSR performance? Market liberalization brings about changes.
    Zhou H; Xu L
    Heliyon; 2023 Nov; 9(11):e22172. PubMed ID: 38045161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyst optimism, information disclosure, and stock price collapse risk: Empirical insights from China's A-share market.
    Li Y; Zhang Y; Ma R; Wang R
    PLoS One; 2024; 19(3):e0297055. PubMed ID: 38547105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic-Based on Cases of Dominant Listed Companies.
    Ye R; An N; Xie Y; Luo K; Lin Y
    Front Public Health; 2021; 9():663189. PubMed ID: 34041217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate climate risk and stock market reaction to performance briefings in China.
    Wu N; Xiao W; Liu W; Zhang Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):53801-53820. PubMed ID: 35290587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do controlling shareholders' equity pledges exacerbate the stock price crash risk? -A study based on margin trading and securities lending transactions in China's securities market.
    Wang L; Cao Z; Cao W
    Heliyon; 2024 Sep; 10(18):e37473. PubMed ID: 39309845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. China's Insurance Regulatory Reform, Corporate Governance Behavior and Insurers' Governance Effectiveness.
    Li H; Zhang H; Tsai SB; Qiu A
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29039781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies.
    Chen Y; Wang Y; Zhao H; Xu W
    PLoS One; 2023; 18(1):e0280237. PubMed ID: 36701361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of China's ETS on Corporate Green Governance Based on the Perspective of Corporate ESG Performance.
    Yao R; Fei Y; Wang Z; Yao X; Yang S
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Chinese-style margin trading promote the high-quality development of listed companies?
    Tang J; Wu Y; Ye Y
    PLoS One; 2023; 18(4):e0284947. PubMed ID: 37104370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An empirical study on the asset-light operation and corporate performance of China's tourism listed companies.
    Liang S; Yu R; Liu Z; Wang W; Wu L; Hu X
    Heliyon; 2023 Feb; 9(2):e13391. PubMed ID: 36816312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Officials' promotion expectation, corporate strategic deviance and corporate growth in China: The moderating effect of corporate ownership.
    Li Y; Fang X
    PLoS One; 2023; 18(8):e0284872. PubMed ID: 37624770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental, social, and governance information disclosure and stock price crash risk: Evidence from Chinese listed companies.
    Xu N; Liu J; Dou H
    Front Psychol; 2022; 13():977369. PubMed ID: 36204747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.